This study was undertaken to investigate the relationship between pulmonary hypertension and exercise performance in patients with heart failure.
Exercise intolerance is a serious and almost universal problem in patients with chronic heart failure (1, 2) . In the past, this problem has been attributed primarily to left ventricular dysfunction, impaired skeletal muscle arteriolar vasodilation and changes in skeletal muscle characteristics, possibly due to muscle deconditioning (1) (2) (3) (4) . Relatively little attention has been focused on the pulmonary circulation and right ventricle, aside from reports of a correlation between right ventricular function, pulmonary artery pressures and maximal exercise performance (5) .
Pulmonary hypertension is a well-established complication of chronic heart failure (6, 7) . During exercise, excessive pulmonary vascular resistance theoretically could impair the delivery of blood to the left ventricle and thereby attenuate the cardiac output response to exercise. Therefore, pulmonary hypertension may be an important contributor to exercise intolerance in heart failure.
This study was undertaken to investigate the relationship between pulmonary hypertension and exercise performance in heart failure. Specifically, we sought to define the incidence of pulmonary hypertension in ambulatory patients with heart failure. Second, we examined the relationship between pulmonary vascular resistance (PVR), peak exercise minute oxygen consumption (VO 2 ) and the cardiac output response to exercise.
METHODS
Patient population. The study population consisted of all ambulatory patients with heart failure who underwent right heart catheterization with exercise studies between December 1993 and March 1997. During that time period, right heart catheterization with exercise was used routinely to investigate exercise performance in patients referred to the Vanderbilt Heart Failure and Heart Transplantation Programs. Patients were excluded if their ejection fraction was more than 40%, if they were dependent on inotropic or mechanical support, if they were limited by angina during exercise, or if they exhibited arterial oxygen desaturation during exercise. A total of 320 patients were studied. Average age of these patients was 52 Ϯ 10 years (range: 21 to 75 years). Seventy-four percent of the patients were men. There were approximately equal proportions of patients with ischemic and dilated cardiomyopathy. Left ventricular ejection fraction was 23% Ϯ 9% (range: 8% to 40%). Overall, mean peak VO 2 was 13.0 Ϯ 3.4 ml/min/kg. All patients had exertional dyspnea, fatigue or both and were classified according to New York Heart Association classification between class II to IV.
Protocol.
On the day of the study, patients arrived in the morning at Vanderbilt University Heart Failure and Heart Transplantation Program's catheterization procedure laboratory having fasted overnight. A 7F Swan Ganz thermodilution catheter was inserted percutaneously through an internal jugular vein (brachial vein if internal jugular cannulation unsuccessful) and positioned in the pulmonary artery.
Supine central hemodynamic measurements were obtained that included pulmonary artery pressure, right atrial pressure and pulmonary capillary wedge pressure. Blood pressure was measured by a sphygmomanometer. Supine cardiac output was also determined by thermodilution, in triplicate. Blood samples were drawn from the pulmonary artery for measurement of hemoglobin oxygen (O 2 ) saturation.
Patients then stood up on the treadmill and were connected to a Medgraphics Cardio O 2 Metabolic Cart. The patient's left index finger was attached to a pulse oximeter to continuously monitor arterial hemoglobin O 2 saturation.
The patient then began exercising on the treadmill, using a modified Naughton protocol. Each exercise stage lasted 3 min. Speed and grade for each stage was as follows: 1 (1 mph, 0), 2 (2 mph, 0), 3 (2 mph, 3.5), 4 (2 mph, 7), 5 (2 mph, 10.5), 6 (2 mph, 14), 7 (2 mph, 17.5), 8 (2 mph, 21), 9 (2.5 mph, 21), 10 (3 mph, 21). All patients continued exercising until symptoms of dyspnea or fatigue, or both, forced them to stop. Central hemodynamic measurements and respiratory gas exchange analysis were recorded continuously throughout exercise. Blood sampling from the pulmonary artery was performed during the last 45 s of each stage. Derived variables. The following hemodynamic variables were calculated using standard formulas: mean arterial pressure, arteriovenous O 2 difference and systemic vascular resistance. Mean arterial pressure was calculated as diastolic pressure ϩ one-third of the pulse pressure. Total pulmonary resistance was calculated as the mean pulmonary artery pressure divided by the cardiac output. Pulmonary vascular resistance was calculated as (mean pulmonary artery pressure-pulmonary wedge pressure)/cardiac output. Thermodilution cardiac output values were obtained with the patient in the resting supine position whereas Fick cardiac output values were calculated during upright exercise.
Measured variables.

Statistical analysis.
Initially descriptive analyses were performed on all the patients. The patients were then divided into four groups. Group 1 consisted of patients with normal resting PVR (Ͻ1.5 Wood Units). Group 2 had PVR between 1.5 and 2.49 Wood Units, Group 3 had pulmonary vascular resistance between 2.5 and 3.49 Wood Units and Group 4 had Ͼ3.5 Wood Units. These groups were compared for various clinical, hemodynamic and ventilatory parameters. Categorical variables were compared using chisquare test and continuous variables using analysis of variance (ANOVA). A two-tailed p value of Ͻ0.05 was used for statistical significance. When continuous variables were found to be significantly different using ANOVA and a p value Ͻ0.05, post hoc analyzes were performed with unpaired t testing using Bonferonni correction to detect differences between individual classes. Continuous variables are presented as mean Ϯ SD and categorical variables as percentages. SPSS for Windows Release 7 (SPSS Inc., Chicago, Illinois) was used for statistical calculations.
RESULTS
Supine resting and peak exercise hemodynamic responses for the entire population are summarized in Tables 1 and 2 . Resting pulmonary artery pressure averaged 28 Ϯ 11 mm Hg, pulmonary wedge pressure 18 Ϯ 9 mm Hg, total pulmonary resistance 7.06 Ϯ 4.28 Wood Units and PVR 2.45 Ϯ 1.57 Wood Units. With exercise, patients achieved peak VO 2 levels of 13.0 Ϯ 3.4 ml/min/kg. At peak exercise, PVR was unchanged from resting levels (2.41 Ϯ 1.52 Wood Units).
Pulmonary vascular resistance.
Resting PVR was normal (Ͻ1.5 Wood Units; Group 1) in 28% of the patients, mildly elevated (1.5-2.49 Wood Units; Group 2) in 36%, moderately elevated (2.5-3.49 Wood Units; Group 3) in 17%, and severely elevated (Ͼ3.5 Wood Units; Group 4) in 19%. There were no significant differences in these group in their (Table 3 ; Fig. 1 ). However, pulmonary hypertension was observed in patients with preserved exercise capacity as well as in patients with severe exercise intolerance. For example, 18% of the patients in this study had peak exercise VO 2 levels Ͼ16 ml/min/kg. In these patients, 41% had PVR of 1.5-2.49 Wood Units, 5% had pulmonary resistances of 2.5-3.49 Wood Units and 7% had pulmonary resistance Ͼ3.5 Wood Units.
Pulmonary vascular resistance decreased significantly with exercise in patients with severe pulmonary hypertension (Group 4) but increased significantly in patients with normal PVR (Group 1) (Fig. 2) .
Pulmonary wedge pressures decreased during exercise in 28% of the entire population (mean decrease ϭ 5 Ϯ 3 mm Hg), possibly reflecting impaired delivery of blood to the left ventricle. Thirteen percent of the patients in Group 1 decreased their pulmonary wedge pressure with exercise as compared with 22%, 29% and 36% in Groups 2, 3 and 4, respectively (p ϭ 0.005). When compared with patients who increased their pulmonary wedge pressure with exercise, patients who exhibited a decrease in pulmonary wedge pressure during exercise had significantly higher resting PVR (3.65 Ϯ 2.14 vs. 2.25 Ϯ 1.36 Wood Units) and higher right atrial pressures at peak exercise (13 Ϯ 7 vs. 9 Ϯ 7 mm Hg) (both p Ͻ 0.0001).
DISCUSSION
Pulmonary vascular resistance in normal individuals is Ͻ1.5 Wood Units (8) . During exercise, pulmonary pressures increase as a function of increased blood flow. Cardiac output, however, increases out of proportion to pulmonary pressures, resulting in a drop in PVR.
In patients with longstanding heart failure and high pulmonary wedge pressures, several histologic changes occur that lead to initially reversible and then irreversible pulmonary hypertension. These changes include medial hypertrophy, intimal and adventitial fibrosis and focal hemosiderosis (6) . Theoretically, these changes can impair flow through the lungs and contribute to exercise intolerance in heart failure.
To investigate the impact of PVR on exercise performance in heart failure, we examined hemodynamic parameters at rest and during exercise in a large group of patients referred to the Vanderbilt Heart Failure and Transplant Programs. The patients in general had relatively severe exercise intolerance, as evidenced by an average peak exercise VO 2 of 13.4 ml/min/kg. However, 16% of the patients had peak VO 2 levels Ͼ16 ml/min/kg, consistent with Functional Class II exercise limitation.
Incidence of pulmonary hypertension. Seventy-two percent of the patients studied had pulmonary hypertension (Ͼ1.5 Wood Units), including 19% with severe pulmonary hypertension (PVR Ͼ3.5 Wood Units). This frequency of pulmonary hypertension is similar to that observed by Costard-Jackle et al. (9) in 288 patients evaluated at Stanford University Medical Center for heart transplanta- MBP ϭ mean blood pressure; PA ϭ pulmonary artery; PCWP ϭ pulmonary capillary wedge pressure; PVR ϭ pulmonary vascular resistance; RAP ϭ right atrial pressure; TPE ϭ total pulmonary resistance; VO 2 ϭ peak oxygen consumption. tion. These investigators noted that approximately 79% of their patients had pulmonary hypertension, with close to 35% having PVR Ͼ3.5 Wood Units. This high incidence of pulmonary hypertension may reflect a referral bias because patients with mild heart failure are rarely referred to specialty heart failure and heart transplantation programs. Nevertheless, these findings indicate that pulmonary hypertension is an extremely common problem in patients with moderate to severe heart failure. We also noted that some patients with relatively mild exercise symptoms had pulmonary hypertension. For example, 58 of the patients in our study had a peak exercise VO 2 Ͼ16 ml/min/kg, a level of exercise ability usually associated with only mild exertional symptoms. In these patients, 41% had PVRs of 1.5 to 2.49 Wood Units, 5% had pulmonary resistances of 2.5 to 3.49 Wood Units and 7% had pulmonary resistance Ͼ3.5 Wood Units. Therefore, the absence of major exertional symptoms does not exclude the possibility of severe pulmonary hypertension.
Effect of exercise on pulmonary resistance. During exercise, PVR changed relatively little, despite an increase in cardiac output. One might expect that an increase in cardiac output and pulmonary flow during exercise would produce pulmonary vasodilation, due to recruitment and distention of the pulmonary vascular bed. Instead, we observed a decrease in resistance in patients with high resting pulmonary vascular resistance but an increase in patients with normal resistance.
A similar response was noted by Janicki et al. (10) . These investigators observed that pulmonary resistance increased by 0.22 Wood Units in patients with initial PVR Ͻ1.5 Wood Units whereas pulmonary resistance decreased by 1.2 Wood Unit in patients with initial PVR Ͼ3.5 Wood Units. The reason for this response is unclear, although the degree of change in either direction is small and unlikely to be physiologically important.
Effect of pulmonary hypertension on exercise performance. Does the presence of pulmonary hypertension impair exercise performance? In this study, pulmonary hypertension was associated with a reduced peak exercise VO 2 and reduced cardiac output response to exercise, with the degree of exercise abnormalities paralleling the degree of Figure 1 . Resting and peak exercise cardiac output in the patient population (n ϭ 320). Figure 2 . Effect of exercise on pulmonary vascular resistance. 
